Modern approaches to radiotherapy in primary cutaneous lymphomas: insights and recommendations from the DEGRO dermato-oncology working group

Strahlenther Onkol. 2025 Dec;201(12):1249-1253. doi: 10.1007/s00066-025-02453-5. Epub 2025 Sep 9.

Abstract

The growing use of reduced-dose radiotherapy in patients with primary cutaneous lymphoma is a promising development. Nevertheless, the absence of controlled clinical trials to ascertain standardized doses for each specific type constitutes a significant impediment to the advancement of this field. This expert opinion strongly advocates for advancements in radiation oncology practice that address the unique complexities of primary cutaneous lymphoma. By refining our methodologies, we can optimize patient care and outcomes in this dynamic field.

Keywords: IMRT; Overtreatment; Quality of life; S-MISR-Register; Shared decision-making.

Publication types

  • Practice Guideline
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Germany
  • Humans
  • Lymphoma* / radiotherapy
  • Lymphoma, T-Cell, Cutaneous* / radiotherapy
  • Radiation Oncology* / standards
  • Radiotherapy Dosage
  • Skin Neoplasms* / pathology
  • Skin Neoplasms* / radiotherapy